Skip to content
Adverse-event reports (MAUDE)

Read this first: MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line shows reporting volume for the average device in the same FDA product code — a reporting baseline, not a risk measure.

No adverse-event reports are linked to this device.

Recall history
InitiatedRecall #ClassStatusReasonQuantityLink basis
2024-05-13Z-2174-2024Class IIOpen, ClassifiedThe reason for recall is the meters may show an incorrect measurement unit (mmol/L rather than mg/dL) and may result in the wrong unit of measure. Which may subsequently cause an error in interpreting a result as approximately 18 times lower that the actual blood glucose. Potential immediate health consequences of the glucose meter providing a reading in the wrong units of measurement (UOM) may result in inappropriate rescue therapy for presumed hypoglycemia including urgent and repeat administration of carbohydrates. This in turn could lead to frequent episodes of hyperglycemia which is unrecognized and undertreated.Long range consequences of continued use of the affected meters could include mismanagement of the patient s diabetes for longer periods of time potentially resulting in a major health event (in general persistent and/or severe hyperglycemia) that may lead them to seek medical attention, and depending on the duration of hyperglycemia, could contribute to the development of microvascular (i.e., retinopathy, neuropathy, nephropathy) and/or macrovascular (i.e., myocardial infarction, ischemic stroke) complications of diabetes and could lead to fetal damage (abnormal fetal growth and altered organ development and maturation, fetal hypoxemia, spontaneous abortion, and congenital anomalies) in pregnant women. This issue was identified by three initial consumer complaints, with reports that the meters were presenting the incorrect unit of measure.Distribution: Nationwide and Worldwide48 unitsclearance family
2019-09-30Z-0747-2020Class IITerminatedPotential power issues with the Accu-Chek Guide Blood Glucose Monitoring System.Distribution: US Nationwide distribution and countries of AR, AT, AU, BE, BR, CA, CH, CL, DE, DK, EC, ES, FI, FR, GB, GR, HK, HR, ID, IN, IT, JP, KR, LB, LT, LU, MM, MY, NL, NO, PH, PK, PT, SE, SG, TH, TW, ZA.318,678clearance family
Regulatory clearances
  • 510(k)K160944Substantially equivalent (SESE) · 2016-08-31clearance family

Predicate lineage

K160944

Cited as predicate by: K203711, K213131

Lineage each submission cites, walked transitively (indented = the cited device's own predicates). Extracted from public 510(k) summary text — heuristic, and includes reference devices mentioned alongside true predicates.

Manufacturer compliance record
DateTypeOutcomeFacilityCitations
2023-11-30NAINo action indicatedRoche Molecular Systems, Inc.0
2022-12-07NAINo action indicatedRoche Diagnostics Operations, Inc.0
2022-09-23NAINo action indicatedVentana Medical Systems, Inc.0
2022-09-15NAINo action indicatedVentana Medical Systems, Inc.0
2021-07-29NAINo action indicatedVentana Medical Systems, Inc.0
2020-02-26NAINo action indicatedVentana Medical Systems, Inc.0
2019-08-29VAIVoluntary action indicatedRoche Diagnostics GmbH0
2019-08-14NAINo action indicatedVentana Medical Systems, Inc.0
2019-07-25VAIVoluntary action indicatedRoche Diabetes Care, Inc.3
2019-06-27VAIVoluntary action indicatedRoche Diagnostics Operations, Inc.1
2018-04-19NAINo action indicatedRoche Diagnostics GmbH0
2018-04-12NAINo action indicatedRoche Diagnostics GmbH0
2017-07-24NAINo action indicatedRoche Molecular Systems, Inc.0
2017-07-13NAINo action indicatedVentana Medical Systems, Inc.0
2017-02-27NAINo action indicatedRoche Molecular Systems, Inc.0
2017-02-02VAIVoluntary action indicatedRoche Diabetes Care GmbH1
2016-11-18NAINo action indicatedRoche Diagnostics GmbH0
2016-10-14NAINo action indicatedRoche Diagnostics Operations, Inc.0
2016-09-01NAINo action indicatedRoche Molecular Systems, Inc.0
2016-08-15VAIVoluntary action indicatedRoche Diagnostics Operations, Inc.1
Similar devices
Select up to two to place side-by-side with this device.